Search Results - "Clinical Decision-Making [MeSH]"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Source: Breast Cancer Res Treat

  5. 5
  6. 6

    Source: Surg Endosc
    Surgical Endoscopy, 38 (5), 2483–2496

    File Description: application/pdf; ZORA_276738.pdf - application/pdf

  7. 7
  8. 8

    Source: Int J Cardiovasc Imaging

    File Description: pdf

  9. 9
  10. 10
  11. 11

    Source: Cardiovascular Research. 118(1)

    Subject Terms: 3206 Medical Biotechnology (for-2020), 32 Biomedical and Clinical Sciences (for-2020), Stem Cell Research - Induced Pluripotent Stem Cell (rcdc), Cardiovascular (rcdc), Orphan Drug (rcdc), Stem Cell Research - Induced Pluripotent Stem Cell - Human (rcdc), Stem Cell Research (rcdc), Rare Diseases (rcdc), Heart Disease (rcdc), 5.2 Cellular and gene therapies (hrcs-rac), Generic health relevance (hrcs-hc), Cardiovascular (hrcs-hc), 3 Good Health and Well Being (sdg), Biomedical Research (mesh), Cardiology (mesh), Cardiotoxicity (mesh), Cardiovascular Agents (mesh), Cardiovascular Diseases (mesh), Cell Culture Techniques, Three Dimensional (mesh), Cell Differentiation (mesh), Cell Proliferation (mesh), Clinical Decision-Making (mesh), Drug Discovery (mesh), Humans (mesh), Induced Pluripotent Stem Cells (mesh), Myocytes, Cardiac (mesh), Phenotype (mesh), Risk Assessment (mesh), Toxicity Tests (mesh), Induced pluripotent stem cells, Cardiomyocytes, Disease modelling, Drug screening, Multicellular crosstalk, 3D platforms, Induced pluripotent stem cells, Cardiomyocytes, Disease modelling, Drug screening, Multicellular crosstalk, 3D platforms, Myocytes, Cardiac (mesh), Humans (mesh), Cardiovascular Diseases (mesh), Cardiovascular Agents (mesh), Risk Assessment (mesh), Toxicity Tests (mesh), Cardiology (mesh), Cell Differentiation (mesh), Cell Proliferation (mesh), Phenotype (mesh), Biomedical Research (mesh), Drug Discovery (mesh), Induced Pluripotent Stem Cells (mesh), Cardiotoxicity (mesh), Clinical Decision-Making (mesh), Cell Culture Techniques, Three Dimensional (mesh), 3D platforms, Cardiomyocytes, Disease modelling, Drug screening, Induced pluripotent stem cells, Multicellular crosstalk, Biomedical Research (mesh), Cardiology (mesh), Cardiotoxicity (mesh), Cardiovascular Agents (mesh), Cardiovascular Diseases (mesh), Cell Culture Techniques, Three Dimensional (mesh), Cell Differentiation (mesh), Cell Proliferation (mesh), Clinical Decision-Making (mesh), Drug Discovery (mesh), Humans (mesh), Induced Pluripotent Stem Cells (mesh), Myocytes, Cardiac (mesh), Phenotype (mesh), Risk Assessment (mesh), Toxicity Tests (mesh), 1102 Cardiorespiratory Medicine and Haematology (for), Cardiovascular System & Hematology (science-metrix), 3201 Cardiovascular medicine and haematology (for-2020)

  12. 12

    Source: European Urology. 79(6)

    Subject Terms: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Prostate Cancer (rcdc), Clinical Research (rcdc), Genetics (rcdc), Biotechnology (rcdc), Urologic Diseases (rcdc), Genetic Testing (rcdc), Human Genome (rcdc), Cancer Genomics (rcdc), Cancer (rcdc), Aging (rcdc), Precision Medicine (rcdc), 4.1 Discovery and preclinical testing of markers and technologies (hrcs-rac), 4.2 Evaluation of markers and technologies (hrcs-rac), Cancer (hrcs-hc), Generic health relevance (hrcs-hc), 3 Good Health and Well Being (sdg), Biomarkers, Tumor (mesh), Circulating Tumor DNA (mesh), Clinical Decision-Making (mesh), Humans (mesh), Liquid Biopsy (mesh), Male (mesh), Neoplastic Cells, Circulating (mesh), Prostatic Neoplasms (mesh), Prostate cancer, Genomics, Liquid biopsy, Circulating tumor cell, Circulating tumor DNA, Extracellular vesicles, Precision medicine, Humans (mesh), Prostatic Neoplasms (mesh), Male (mesh), Neoplastic Cells, Circulating (mesh), Biomarkers, Tumor (mesh), Clinical Decision-Making (mesh), Liquid Biopsy (mesh), Circulating Tumor DNA (mesh), Circulating tumor DNA, Circulating tumor cell, Extracellular vesicles, Genomics, Liquid biopsy, Precision medicine, Prostate cancer, Biomarkers, Tumor (mesh), Circulating Tumor DNA (mesh), Clinical Decision-Making (mesh), Humans (mesh), Liquid Biopsy (mesh), Male (mesh), Neoplastic Cells, Circulating (mesh), Prostatic Neoplasms (mesh), 1103 Clinical Sciences (for), Urology & Nephrology (science-metrix), 3202 Clinical sciences (for-2020)

    File Description: application/pdf

  13. 13

    Source: Clinical Breast Cancer. 20(3)

    Subject Terms: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Radiation Oncology (rcdc), Women's Health (rcdc), Clinical Research (rcdc), Breast Cancer (rcdc), Clinical Trials and Supportive Activities (rcdc), Cancer (rcdc), 6.4 Surgery (hrcs-rac), 6.5 Radiotherapy and other non-invasive therapies (hrcs-rac), Cancer (hrcs-hc), Breast Neoplasms, Male (mesh), Clinical Decision-Making (mesh), Decision Making, Shared (mesh), Disease-Free Survival (mesh), Humans (mesh), Male (mesh), Mastectomy, Segmental (mesh), Neoplasm Recurrence, Local (mesh), Patient Compliance (mesh), Prospective Studies (mesh), Radiotherapy, Adjuvant (mesh), Retrospective Studies (mesh), Breast conserving therapy, Lumpectomy, Men, Radiation, Survival, Humans (mesh), Breast Neoplasms, Male (mesh), Neoplasm Recurrence, Local (mesh), Disease-Free Survival (mesh), Radiotherapy, Adjuvant (mesh), Mastectomy, Segmental (mesh), Retrospective Studies (mesh), Prospective Studies (mesh), Patient Compliance (mesh), Male (mesh), Clinical Decision-Making (mesh), Decision Making, Shared (mesh), Breast conserving therapy, Lumpectomy, Men, Radiation, Survival, Breast Neoplasms, Male (mesh), Clinical Decision-Making (mesh), Decision Making, Shared (mesh), Disease-Free Survival (mesh), Humans (mesh), Male (mesh), Mastectomy, Segmental (mesh), Neoplasm Recurrence, Local (mesh), Patient Compliance (mesh), Prospective Studies (mesh), Radiotherapy, Adjuvant (mesh), Retrospective Studies (mesh), Oncology & Carcinogenesis (science-metrix), 3211 Oncology and carcinogenesis (for-2020)

    File Description: application/pdf

  14. 14

    Source: Circulation. 141(19)

    Subject Terms: 4202 Epidemiology (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 4206 Public Health (for-2020), 42 Health Sciences (for-2020), Heart Disease - Coronary Heart Disease (rcdc), Prevention (rcdc), Heart Disease (rcdc), Cardiovascular (rcdc), Aging (rcdc), Atherosclerosis (rcdc), Clinical Research (rcdc), 4.2 Evaluation of markers and technologies (hrcs-rac), 3.1 Primary prevention interventions to modify behaviours or promote wellbeing (hrcs-rac), Cardiovascular (hrcs-hc), 3 Good Health and Well Being (sdg), Aged (mesh), Aged, 80 and over (mesh), Aspirin (mesh), Clinical Decision-Making (mesh), Computed Tomography Angiography (mesh), Coronary Angiography (mesh), Coronary Artery Disease (mesh), Female (mesh), Heart Disease Risk Factors (mesh), Hemorrhage (mesh), Humans (mesh), Incidence (mesh), Male (mesh), Middle Aged (mesh), Myocardial Infarction (mesh), Platelet Aggregation Inhibitors (mesh), Primary Prevention (mesh), Prospective Studies (mesh), Risk Assessment (mesh), Stroke (mesh), Time Factors (mesh), Treatment Outcome (mesh), United States (mesh), Vascular Calcification (mesh), aspirin, calcium, cardiovascular diseases, hemorrhage, risk, safety, Humans (mesh), Myocardial Infarction (mesh), Hemorrhage (mesh), Aspirin (mesh), Platelet Aggregation Inhibitors (mesh), Coronary Angiography (mesh), Treatment Outcome (mesh), Incidence (mesh), Risk Assessment (mesh), Prospective Studies (mesh), Primary Prevention (mesh), Time Factors (mesh), Aged (mesh), Aged, 80 and over (mesh), Middle Aged (mesh), United States (mesh), Female (mesh), Male (mesh), Coronary Artery Disease (mesh), Stroke (mesh), Vascular Calcification (mesh), Clinical Decision-Making (mesh), Computed Tomography Angiography (mesh), Heart Disease Risk Factors (mesh), aspirin, calcium, cardiovascular diseases, hemorrhage, risk, safety, Aged (mesh), Aged, 80 and over (mesh), Aspirin (mesh), Clinical Decision-Making (mesh), Computed Tomography Angiography (mesh), Coronary Angiography (mesh), Coronary Artery Disease (mesh), Female (mesh), Heart Disease Risk Factors (mesh), Hemorrhage (mesh), Humans (mesh), Incidence (mesh), Male (mesh), Middle Aged (mesh), Myocardial Infarction (mesh), Platelet Aggregation Inhibitors (mesh), Primary Prevention (mesh), Prospective Studies (mesh), Risk Assessment (mesh), Stroke (mesh), Time Factors (mesh), Treatment Outcome (mesh), United States (mesh), Vascular Calcification (mesh), 1102 Cardiorespiratory Medicine and Haematology (for), 1103 Clinical Sciences (for), 1117 Public Health and Health Services (for), Cardiovascular System & Hematology (science-metrix), 3201 Cardiovascular medicine and haematology (for-2020), 3202 Clinical sciences (for-2020), 4207 Sports science and exercise (for-2020)

    File Description: application/pdf

  15. 15
  16. 16

    Source: BMC Cancer
    BMC Cancer, Vol 24, Iss 1, Pp 1-14 (2024)

  17. 17

    Source: BMC Med Inform Decis Mak
    BMC Medical Informatics and Decision Making, Vol 24, Iss 1, Pp 1-9 (2024)
    BMC medical informatics and decision making

  18. 18

    Source: Journal of Cardiovascular Computed Tomography. 13(4)

    Subject Terms: 32 Biomedical and Clinical Sciences (for-2020), 3201 Cardiovascular Medicine and Haematology (for-2020), 3202 Clinical Sciences (for-2020), 46 Information and Computing Sciences (for-2020), 4601 Applied Computing (for-2020), Human Genome (rcdc), Prevention (rcdc), Cardiovascular (rcdc), Heart Disease - Coronary Heart Disease (rcdc), Clinical Research (rcdc), Heart Disease (rcdc), Atherosclerosis (rcdc), Genetics (rcdc), Aging (rcdc), Cardiovascular (hrcs-hc), Adult (mesh), Age Factors (mesh), Aged (mesh), Aged, 80 and over (mesh), Clinical Decision-Making (mesh), Coronary Angiography (mesh), Coronary Artery Disease (mesh), Female (mesh), Genetic Predisposition to Disease (mesh), Genetic Testing (mesh), Humans (mesh), Male (mesh), Middle Aged (mesh), Phenotype (mesh), Polymorphism, Single Nucleotide (mesh), Predictive Value of Tests (mesh), Risk Assessment (mesh), Risk Factors (mesh), United States (mesh), Vascular Calcification (mesh), Coronary heart disease, Coronary artery calcium, Screening, Genetics, Genetic risk score, CAC, Humans (mesh), Genetic Predisposition to Disease (mesh), Coronary Angiography (mesh), Risk Assessment (mesh), Risk Factors (mesh), Predictive Value of Tests (mesh), Age Factors (mesh), Phenotype (mesh), Polymorphism, Single Nucleotide (mesh), Adult (mesh), Aged (mesh), Aged, 80 and over (mesh), Middle Aged (mesh), United States (mesh), Female (mesh), Male (mesh), Coronary Artery Disease (mesh), Genetic Testing (mesh), Vascular Calcification (mesh), Clinical Decision-Making (mesh), CAC, Coronary artery calcium, Coronary heart disease, Genetic risk score, Genetics, Screening, Adult (mesh), Age Factors (mesh), Aged (mesh), Aged, 80 and over (mesh), Clinical Decision-Making (mesh), Coronary Angiography (mesh), Coronary Artery Disease (mesh), Female (mesh), Genetic Predisposition to Disease (mesh), Genetic Testing (mesh), Humans (mesh), Male (mesh), Middle Aged (mesh), Phenotype (mesh), Polymorphism, Single Nucleotide (mesh), Predictive Value of Tests (mesh), Risk Assessment (mesh), Risk Factors (mesh), United States (mesh), Vascular Calcification (mesh), 1102 Cardiorespiratory Medicine and Haematology (for), 1103 Clinical Sciences (for), Cardiovascular System & Hematology (science-metrix), 3201 Cardiovascular medicine and haematology (for-2020), 3202 Clinical sciences (for-2020), 4601 Applied computing (for-2020)

    File Description: application/pdf

  19. 19

    Source: Oral Oncology. 92

    Subject Terms: 32 Biomedical and Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Cancer (rcdc), Dental/Oral and Craniofacial Disease (rcdc), Bioengineering (rcdc), Biomedical Imaging (rcdc), Digestive Diseases (rcdc), Minority Health (rcdc), Clinical Research (rcdc), Health Disparities (rcdc), Rare Diseases (rcdc), 4.2 Evaluation of markers and technologies (hrcs-rac), 4.1 Discovery and preclinical testing of markers and technologies (hrcs-rac), Cancer (hrcs-hc), Adult (mesh), Aged (mesh), Algorithms (mesh), Biopsy (mesh), Clinical Decision-Making (mesh), Disease Management (mesh), Female (mesh), Humans (mesh), Intraoperative Care (mesh), Male (mesh), Margins of Excision (mesh), Middle Aged (mesh), Mouth Neoplasms (mesh), Neoplasm Grading (mesh), Neoplasm Staging (mesh), Point-of-Care Testing (mesh), Sensitivity and Specificity (mesh), Tomography, Optical Coherence (mesh), Oral cancer, Tumor margin, Optical coherence tomography, Field cancerization, Dysplasia, Humans (mesh), Mouth Neoplasms (mesh), Tomography, Optical Coherence (mesh), Biopsy (mesh), Neoplasm Staging (mesh), Intraoperative Care (mesh), Sensitivity and Specificity (mesh), Algorithms (mesh), Adult (mesh), Aged (mesh), Middle Aged (mesh), Disease Management (mesh), Female (mesh), Male (mesh), Neoplasm Grading (mesh), Clinical Decision-Making (mesh), Point-of-Care Testing (mesh), Margins of Excision (mesh), Dysplasia, Field cancerization, Optical coherence tomography, Oral cancer, Tumor margin, Adult (mesh), Aged (mesh), Algorithms (mesh), Biopsy (mesh), Clinical Decision-Making (mesh), Disease Management (mesh), Female (mesh), Humans (mesh), Intraoperative Care (mesh), Male (mesh), Margins of Excision (mesh), Middle Aged (mesh), Mouth Neoplasms (mesh), Neoplasm Grading (mesh), Neoplasm Staging (mesh), Point-of-Care Testing (mesh), Sensitivity and Specificity (mesh), Tomography, Optical Coherence (mesh), 1105 Dentistry (for), 1112 Oncology and Carcinogenesis (for), 1117 Public Health and Health Services (for), Dentistry (science-metrix), Oncology & Carcinogenesis (science-metrix), 3203 Dentistry (for-2020), 3211 Oncology and carcinogenesis (for-2020)

    File Description: application/pdf

  20. 20

    Source: Annals of Surgery, vol Publish Ahead of Print, iss &NA

    File Description: application/pdf